Thought Leader Select Begins Oncology Thought Leader Assessment in Canada

March 16, 2011 · Leave a comment

March 16, 2011 (CHAPEL HILL, NC)—Research Triangle, NC research and consulting firm Thought Leader Select has initiated a new assessment of medical experts in the field of oncology for the biopharmaceutical industry.

A Canadian subsidiary of a top 10 global biopharmaceutical company has hired the firm to study the skills and experiences of 40 key opinion leaders in the treatment of lung cancer.  Thought Leader Select is offering the client company an objective, systematic foundational approach to selecting physicians and other health care professionals within the Canadian care environment to assist the company during its stretch-run of activities in support of the new cancer treatment’s development.

The selected key opinion leaders in Canadian oncology circles will provide a variety of services to the company, including advisory board participation, conducting clinical studies, and offering one-on-one consultations with the company’s scientific and medical teams.  Thought Leader Select’s methodology, while compliant with Office of Inspector General guidelines in the United States, is also compliant with Canadian regulations such as the Personal Information Protection and Electronic Documents Act (PIPEDA).

“We have been privileged to work with this company on multiple projects in several therapeutic areas, to ensure that its new product teams are positioned for success by working with the right thought leaders for the right reasons,” stated Neil Mellor, Thought Leader Select’s business development consultant.  “This ... read more »

TAGS: